- Filed
- Mar 25, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $13.25M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $16.41M |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 17.34M sh |
| Capex | FY 2024 · Dec 31, 2023 | $52.09K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$11.37M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $17.51M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $3.72M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.72M |
| Current Assets | FY 2024 · Dec 31, 2023 | $19.79M |
| Total Assets | FY 2024 · Dec 31, 2023 | $19.93M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.89 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.89 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $7.41M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $8.74M |
| Net Income | FY 2024 · Dec 31, 2023 | −$15.43M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$16.14M |